Expression of neuropilin-1 on in vivo induced regulatory T cells by Christopher J Nirschl et al.
POSTER PRESENTATION Open Access
Expression of neuropilin-1 on in vivo induced
regulatory T cells
Christopher J Nirschl1,2*, Christina Ceccato1,2, Angela Alme1,2, Brian Francica1,2, Charles G Drake1,2,3
From Society for Immunotherapy of Cancer 28th Annual Meeting
National Harbor, MD, USA. 8-10 November 2013
One of the current questions surrounding CD4 T regula-
tory cells (Tregs) is the role of natural and induced Tregs
in tumor tolerance. Natural Tregs are CD4 T cells that
leave the thymus expressing FoxP3 and displaying regula-
tory potential. Induced Tregs leave the thymus as a naïve
CD4 T cell (FoxP3-), but are skewed by conditions
encountered during antigen recognition to express FoxP3
and gain regulatory function. Several groups have recently
suggested that Neuropilin-1 may be a suitable marker for
natural Tregs. To examine the ability of neuropilin-1 to
identify natural versus in vivo induced Tregs, we bred a
CD4 T cell receptor transgenic mouse specific for HA
(6.5) onto a Rag-2 -/- background. The resultant 6.5 Rag
-/- mice have no Tregs (as defined by FoxP3 expression),
as has been noted for other TCR transgenic models, and
express no neuropilin-1 (or CD25) prior to manipulation.
To test whether neuropilin-1 was expressed on in vivo
induced Tregs we performed a series of adoptive transfer
studies into A) non-transgenic hosts, followed by low dose
i.v. HA peptide administration B) self antigen expressing
animals (C3-HAlow) or C) tumor antigen expressing mice
(established HA expressing 4T1 mammary carcinomas).
Our data show that in vivo induced Tregs clearly express
neuropilin-1 under these various conditions. Furthermore,
neuropilin-1 expression was found on both FoxP3+ and
FoxP3- populations in all three models of in vivo induced
Tregs, suggesting that neuropilin-1 is expressed on acti-
vated cells. Consistent with this notion, we found that
neuropilin-1 was strongly upregulated within the first sev-
eral divisions on 6.5 CD4 T cells when adoptively trans-
ferred into a host receiving HA expressing Vaccinia Virus.
CD25 expression was more closely associated with FoxP3
expression than neuropilin-1: In the low dose i.v. peptide
model, neuropilin-1+ CD25+ 6.5 CD4 T cells were signifi-
cantly enriched for FoxP3 and Helios expression, whereas
neuropilin-1+ CD25- 6.5 CD4 T cells were not. Tumor
induced 6.5 CD4 Tregs also expressed low levels of neuro-
pilin-1, even though the majority of 6.5 CD4 T cells were
not induced to express FoxP3 by tumor antigen recogni-
tion. These data strongly support the notion that neuropi-
lin-1 is not a specific marker of natural Tregs in mice, and
further suggest that the majority of FoxP3+ TILS are likely
natural Tregs, rather than induced Tregs.
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